P38 MAPK inhibitor semapimod reduces postoperative ileus via peripheral and central mechanisms.
de Jonge
Wouter J
WJ
The
Frans O
FO
Löwenberg
Mark
M
Boeckxstaens
Guy E
GE
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology / Q000627:therapeutic use*; D006835:Hydrazones / Q000494:pharmacology / Q000627:therapeutic use*; D045823:Ileus / Q000503:physiopathology / Q000517:prevention & control*; D051379:Mice; D011183:Postoperative Complications / Q000517:prevention & control*; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors*; D000813:Anilides; D006146:Guanidines
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006835:Hydrazones; D048051:p38 Mitogen-Activated Protein Kinases; C097256:semapimod; D000813:Anilides; D006146:Guanidines